Cargando…
Development of the Swiss Database for dosing medicinal products in pediatrics
In daily paediatrics, drugs are commonly used off-label, as they are not approved for children. Approval is lacking because the required clinical studies were limited to adults in the past. Without clinical studies, evidence-based recommendations for drug use in children are limited. Information on...
Autores principales: | Tilen, Romy, Panis, Dalibor, Aeschbacher, Samuel, Sabine, Thomas, Meyer zu Schwabedissen, Henriette E., Berger, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897330/ https://www.ncbi.nlm.nih.gov/pubmed/34739591 http://dx.doi.org/10.1007/s00431-021-04304-8 |
Ejemplares similares
-
SwissPK(cdw) – A clinical data warehouse for the optimization of pediatric dosing regimens
por: Goers, Roland, et al.
Publicado: (2021) -
Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
por: Wittwer, Nina L, et al.
Publicado: (2022) -
Pharmacogenetic Analysis of Voriconazole Treatment in Children
por: Tilen, Romy, et al.
Publicado: (2022) -
Gentamicin Population Pharmacokinetics in Pediatric Patients—A Prospective Study with Data Analysis Using the saemix Package in R
por: Paioni, Paolo, et al.
Publicado: (2021) -
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
por: Jeiziner, Chiara, et al.
Publicado: (2022)